Neutral impactSector

'Mere Farce': Ajay Devgn Challenges FDA Notice Over Vimal Elaichi Endorsement

NDTV Profit 1 hr ago·3 Nov 2026, 8:36 am

Ajay Devgn takes the Vimal Elaichi ad dispute to the Bombay High Court.

Key takeaways

  • Category: Sector.

Why it matters

A routine update. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NDTV Profit.

More Sector news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.